Clinical Trials Browser

Phase 1 × Immunoglobulin Light-chain Amyloidosis × pomalidomide × Clear all

NCT01728259 2023-05-09

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis